Results 181 to 190 of about 9,635 (207)

Ivacaftor/lumacaftor

Reactions Weekly, 2023
openaire   +1 more source

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Lancet, The, 2019
Edward F Mckone, Damian G Downey, Eva Van Braeckel   +2 more
exaly  

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine, 2020
Pierre-Régis Burgel, Phillipe Reix, Isabelle Sermet-Gaudelus   +2 more
exaly  

Ivacaftor

Reactions Weekly, 2014
openaire   +2 more sources

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

New England Journal of Medicine, 2017
Anne Munck, Edward F Mckone, Cornelis K Van Der Ent   +2 more
exaly  

Ivacaftor

Reactions Weekly, 2017
openaire   +1 more source

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

New England Journal of Medicine, 2018
Marcus A Mall, Edward F Mckone, Dario Prais   +2 more
exaly  

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

New England Journal of Medicine, 2019
Peter Gordon Middleton, Marcus A Mall, Larry C Lands   +2 more
exaly  

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

New England Journal of Medicine, 2017
Felix C C Ringshausen, John Wilson, Elizabeth Tullis   +2 more
exaly  

Ivacaftor

Reactions Weekly, 2019
openaire   +1 more source